Análisis farmacoeconómico del esquema corto de praziquantel en el tratamiento de la neurocisticercosis / Pharmacoeconomic analysis of the short scheme praziquantel in the treatment of neurocysticercosis
Gac. méd. Méx
;
138(2): 203-207, mar.-abr. 2002.
Article
in Spanish
| LILACS
| ID: lil-333655
ABSTRACT
The effectiveness of the treatment of neurocysticercosis with praziquantel has been assessed in several clinical trials in the last 20 years. Most studies employed a dose of 50 mg/kg/day, three times at day during 2 weeks. Recently, a novel and brief dosage scheme of praziquantel has been described. This scheme employs three doses of 25 mg/kg, and all are administered separately on the same day, with interval of 2 hours. This scheme has a direct impact on direct costs (cost of drugs), with a 90 reduction of the traditional scheme. In addition to a favorable impact on direct costs, the impact on indirect costs is important with the short-scheme, hospitalization in unnecessary, and costs of hospital visits for patient and family is avoided, with subsequent improvement of emotional status and family environment.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Praziquantel
/
Neurocysticercosis
/
Anthelmintics
Type of study:
Health economic evaluation
Limits:
Humans
Language:
Spanish
Journal:
Gac. méd. Méx
Journal subject:
Medicine
Year:
2002
Type:
Article
Affiliation country:
Mexico
Institution/Affiliation country:
Centro de Investigación y Estudios Avanzados/MX
/
Instituto Mexicano del Seguro Social/MX
/
Instituto Nacional de Neurologia y Neurocirugia/MX
/
Instituto Politecnico Nacional/MX
Similar
MEDLINE
...
LILACS
LIS